Stockscreener 앱 받기
12.65
0.47%
-0.06
시간 외 거래:
12.65
전일 마감가:
$12.71
열려 있는:
$12.5
하루 거래량:
161.38K
Relative Volume:
0.62
시가총액:
$507.83M
수익:
$822.31M
순이익/손실:
$-92.19M
주가수익비율:
-5.406
EPS:
-2.34
순현금흐름:
$-1.32M
1주 성능:
+0.00%
1개월 성능:
+8.58%
6개월 성능:
-19.01%
1년 성능:
-2.92%
1일 변동 폭
$12.50
$12.82
1주일 범위
$12.37
$12.99
52주 변동 폭
$10.24
$16.99
Orthofix Medical Inc Stock (OFIX) Company Profile
명칭
Orthofix Medical Inc
전화
214-937-2000
주소
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
12.65 | 510.24M | 822.31M | -92.19M | -1.32M | -2.34 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | TD Cowen | Hold |
| 2025-10-28 | 재개 | Stifel | Buy |
| 2025-01-22 | 개시 | Canaccord Genuity | Buy |
| 2024-11-08 | 업그레이드 | Stifel | Hold → Buy |
| 2024-05-08 | 업그레이드 | ROTH MKM | Neutral → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-09-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-09-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-07-19 | 재개 | BTIG Research | Buy |
| 2022-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2020-10-20 | 개시 | Stifel | Hold |
| 2019-10-29 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-06-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-06-14 | 개시 | Ladenburg Thalmann | Buy |
| 2017-05-23 | 개시 | SunTrust | Buy |
| 2015-07-10 | 개시 | Sidoti | Buy |
| 2013-05-09 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2013-01-08 | 재확인 | Mizuho | Buy |
| 2010-06-21 | 개시 | Boenning & Scattergood | Outperform |
| 2010-03-09 | 재확인 | Jefferies & Co | Buy |
| 2010-02-18 | 업그레이드 | Susquehanna Financial | Neutral → Positive |
| 2010-01-22 | 개시 | Jefferies & Co | Buy |
| 2009-11-03 | 업그레이드 | Wells Fargo | Underperform → Market Perform |
| 2009-07-31 | 재확인 | Jefferies & Co | Buy |
| 2009-07-31 | 업그레이드 | Thomas Weisel | Market Weight → Overweight |
| 2009-05-26 | 재확인 | Jefferies & Co | Buy |
| 2009-04-17 | 다운그레이드 | Wachovia | Mkt Perform → Underperform |
| 2009-02-19 | 개시 | Canaccord Adams | Buy |
| 2008-07-07 | 다운그레이드 | Wachovia | Outperform → Mkt Perform |
모두보기
Orthofix Medical Inc 주식(OFIX)의 최신 뉴스
Orthofix CLO Jorge Cedron sells $47,985 in company stock - Investing.com
Orthofix Medical (OFIX) CLO sells shares for RSU tax obligations - Stock Titan
Orthofix reshuffles spine division leadership, posts preliminary Q1 sales - MSN
Orthofix Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Orthofix Medical, Inc.OFIX - PR Newswire
Street Watch: Is Orthofix Medical Inc part of any ETF2026 AllTime Highs & Daily Technical Stock Forecast Reports - baoquankhu1.vn
OFIX SEC FilingsOrthofix Med Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Closing: Does Orthofix Medical Inc have declining or rising EPSPortfolio Value Report & Verified Short-Term Plans - baoquankhu1.vn
OFIX: Barrington Research Maintains Outperform Rating and Price Target | OFIX Stock News - GuruFocus
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Orthofix Medical (NASDAQ:OFIX) Receives Outperform Rating from Barrington Research - MarketBeat
Bone Growth Stimulator Market size to exceed $2.83 Billion - openPR.com
Orthofix reports preliminary Q1 2026 net sales of USD 196.7M - Medical Buyer
Orthofix Realigns Spine Leadership to Strengthen Focus and Execution - BioSpace
Orthofix restructures spine leadership, reports Q1 sales By Investing.com - Investing.com Australia
OFIX Reports Preliminary First Quarter Sales Results - GuruFocus
Orthofix Realigns Spine Leadership to Strengthen Focus - National Today
Orthofix Medical Inc. Re-Affirms Earnings Guidance for the Full Year 2026 - marketscreener.com
Orthofix Medical (OFIX) Projects FY26 Adjusted EBITDA Between $9 - GuruFocus
Orthofix (OFIX) Streamlines Spine Division Leadership - GuruFocus
Canaccord reiterates Orthofix Medical stock rating on leadership changes By Investing.com - Investing.com South Africa
Canaccord reiterates Orthofix Medical stock rating on leadership changes - Investing.com
Orthofix Realigns Spine Leadership - citybiz
Orthofix Medical Inc. Realigns Spine Leadership and Reports Preliminary Q1 2026 Sales, Reaffirms Full-Year Outlook - Minichart
Orthofix restructures spine leadership, reports Q1 sales - Investing.com
Orthofix Medical IncAnnounces Strategic Realignment Of Spine Leadership Team - TradingView — Track All Markets
Orthofix (NASDAQ: OFIX) posts Q1 prelim sales, realigns spine leadership - Stock Titan
Sell Signal: Is Orthofix Medical Inc a strong growth stock2026 Recap & Fast Moving Market Watchlists - baoquankhu1.vn
Earnings Beat: What is the Moat Score of Orthofix Medical Inc2026 Sector Moves & High Accuracy Trade Signal Alerts - baoquankhu1.vn
AI Stocks: Is Orthofix Medical Inc vulnerable to short sellersTake Profit & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Gap Down: Can Orthofix Medical Inc disrupt its industryPortfolio Profit Report & Daily Growth Stock Tips - baoquankhu1.vn
Analysts Conflicted on These Healthcare Names: Phreesia (PHR), Viridian Therapeutics (VRDN) and Orthofix Medical (OFIX) - The Globe and Mail
OFIX Technical Analysis & Stock Price Forecast - intellectia.ai
Insider Buy: Can Orthofix Medical Inc be the next market leader2026 Buyback Activity & Fast Moving Stock Watchlists - baoquankhu1.vn
US Market Recap: Is Orthofix Medical Inc in a consolidation phase2026 Sector Review & Daily Growth Stock Tips - baoquankhu1.vn
Swing Trade: Is Orthofix Medical Inc showing insider buyingMarket Trend Report & Smart Money Movement Tracker - baoquankhu1.vn
Vanguard realignment lists 0% stake in Orthofix (OFIX) after reporting change - Stock Titan
Tudor Investment Corp ET AL Purchases 158,197 Shares of Orthofix Medical Inc. $OFIX - MarketBeat
Sentiment Watch: Is Orthofix Medical Inc a good ESG investment2026 Fed Impact & Short-Term Trading Alerts - baoquankhu1.vn
Hedge Fund Moves: Should I trade or invest in Orthofix Medical IncEarnings Risk Summary & Fast Moving Trade Plans - baoquankhu1.vn
Orthofix Medical Inc. (NASDAQ:OFIX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Is Orthofix Medical Inc showing insider buyingEarnings Growth Report & High Accuracy Buy Signal Tips - baoquankhu1.vn
OFIX PE Ratio & Valuation, Is OFIX Overvalued - Intellectia AI
Smart Money: Is Orthofix Medical Inc stock a value trapMarket Growth Review & Daily Volume Surge Signals - baoquankhu1.vn
Bull Run: Can Orthofix Medical Inc beat the S P 5002026 Price Momentum & Safe Capital Preservation Plans - baoquankhu1.vn
What dividend growth rate does Orthofix Medical Inc offer2026 Highlights & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
(OFIX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Lucas Vitale Sells 4,269 Shares of Orthofix Medical (NASDAQ:OFIX) Stock - MarketBeat
Orthofix (OFIX) executive logs tax-related sale, retains over 160K shares - Stock Titan
Orthofix Medical Inc Aktie: Analyst Upgrades Signal Growing Confidence in Bone-Filler Market Expansi - AD HOC NEWS
Orthofix medical CP&BOO Vitale Lucas sells $29k in stock - Investing.com Nigeria
Down 12.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Orthofix (OFIX) - Yahoo Finance
Orthofix Medical Inc (OFIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
1.72%
자본화:
|
볼륨(24시간):